Drug shortage: Amino Acid Injection (TRAVASOL, AMINOSYN-PF, PLENAMINE)
FDA lists 16 presentations as Current. Availability: Unavailable (3), Available (13). Reason: Shortage of an active ingredient; Shortage of an inactive ingredient component. Companies: Baxter Healthcare, Otsuka ICU Medical LLC, B. Braun Medical Inc..
- Published by source
- 2020-12-08
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Amino Acid Injection TRAVASOL AMINOSYN-PF PLENAMINE PREMASOL - SULFITE-FREE (AMINO ACID) AMINOSYN II TROPHAMINE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
- Estimated recovery: December 2026
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-12-08
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #898 | new | 2026-10-22 | bf1a972e461d…f78d45 | ffb7d5ee6e1b…ea4b59 |
| #1145 | update | 2026-10-23 | 9344ba2dc0b0…2577cb | 1810018de2f2…52d845 |
Chain head: #1250 0c9a4a81d7d8…29590d